Nucleus Network (formerly Q-Pharm)

Nucleus Networks Brisbane facility (originally Q-Pharm) is a dedicated 65-bed clinical trial unit located at the Royal Brisbane and Womens Hospital. Australias second largest Phase 1 unit (second only to Nucleus Network Melbourne), the Brisbane unit undertakes clinical trials for companies and researchers who are developing new, safer or more effective medicines. The benefits of conducting clinical trials at Q-Pharm are: - Reliable and extensive experience over 15 years with 400+ Early Phase studies successfully completed and 15000+ participants recruited - Fast clinical trial start-up (~4-6 weeks from ethics submission to commencement of the clinical trial) - Frequent dates for...

Early phase and vaccine clinical trials,healthy volunteer clinical trials,first in human clinical trials,early phase patient trials,and clinical trial recruitment

Nucleus network (formerly q-pharm) operates in the Research services industry.

Nucleus network (formerly q-pharm)'s revenue is 11m - 100m

Nucleus network (formerly q-pharm) has 11 - 50 employees.